• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Sy Mukherjee

Sy Mukherjee is a former health care reporter for Fortune.

Brainstorm Health Daily: June 13, 2017
HealthBrainstorm Health Daily: June 13, 2017
By Clifton Leaf and Sy MukherjeeJune 13, 2017
Trading On The Floor Of The NYSE As U.S. Stocks Rise Amid Stronger Job Gains Boost Optimism On Economy
HealthThis Biotech’s Stock Plunged 24% After the FDA Rejected Its Amgen Drug Copycat
By Sy MukherjeeJune 12, 2017
Senate Lawmakers Speak To The Press After Their Weekly Policy Luncheons
HealthThe Senate Is Finalizing a Health Care Bill But You’re Not Allowed to See It
By Sy MukherjeeJune 12, 2017
Brainstorm Health Daily: June 12, 2017
HealthBrainstorm Health Daily: June 12, 2017
By Clifton Leaf and Sy MukherjeeJune 12, 2017
Birth Control
HealthThis Birth Control Is Being Recalled After Pills Were Packaged Out of Order
By Sy MukherjeeJune 9, 2017
Brainstorm Health Daily: June 9, 2017
HealthBrainstorm Health Daily: June 9, 2017
By Clifton Leaf and Sy MukherjeeJune 9, 2017
Hands Presenting Heart
HealthAmerica’s Heart Health Divide Is Linked to How Much Money You Make
By Sy MukherjeeJune 8, 2017
Brainstorm Health Daily: June 8, 2017
HealthBrainstorm Health Daily: June 8, 2017
By Clifton Leaf and Sy MukherjeeJune 8, 2017
New York Attorney General Eric T. Schneiderman Announces Large Heroin Bust
HealthWhy Fentanyl Terrifies the DEA and Medical Experts Even More Than Other Opioids
By Sy MukherjeeJune 7, 2017
Brainstorm Health Daily: June 7, 2017
HealthBrainstorm Health Daily: June 7, 2017
By Clifton Leaf and Sy MukherjeeJune 7, 2017
Forbes Under 30 Summit
HealthThis 31-Year-Old Just Launched His 5th Biotech Company With a Boost From Merck
By Sy MukherjeeJune 6, 2017
Johns Hopkins Hospital Continues Cancer Research And Treatment
Health3 Key Takeaways from the World’s Biggest Cancer Conference
By Sy MukherjeeJune 6, 2017
Brainstorm Health Daily: June 6, 2017
HealthBrainstorm Health Daily: June 6, 2017
By Clifton Leaf and Sy MukherjeeJune 6, 2017
Johnson & Johnson Drug Slashes Prostate Cancer Death Risk By Nearly 40%
HealthJohnson & Johnson Drug Slashes Prostate Cancer Death Risk By Nearly 40%
By Sy MukherjeeJune 5, 2017
Herceptin Approved For Treatment Of Scottish Breast Cancer Patients
HealthRoche Loses Billions in Value After Pricey Breast Cancer Drug Combo Disappoints
By Sy MukherjeeJune 5, 2017
1...
  • 86
  • 87
  • 88
  • 89
  • 90
...100
Most Popular
Personal Finance
Social Security's 2032 deadline puts a 22% cut on the table — but Washington has way less room to negotiate than 1983placeholder alt text
By John W. Diamond and The ConversationJune 12, 2026
Success
CEO of $20 billion AI firm Perplexity says the secret to success is ‘sleeping with that fear’ that your competitor will steal your ideaplaceholder alt text
By Preston ForeJune 13, 2026
Economy
Boomers actually do hold most of the wealth and power. So why do they call it 'whiny' to point that out?placeholder alt text
By Nick LichtenbergJune 14, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.